Main Subject - Business

For a growing incorporation with increasing profitability and productivity, an Initial Public Offering (IPO) is the next logical step to take in order to obtain further financi

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

ng. Once the corporation has fulfilled the requirements set by the authorities, going for listing is a fairly straightforward exercise.

A corporation that wants to go public

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

as to fulfill the Stock Exchange's listing requirements and the Securities Commission's policies and guidelines. It must also comply with legal and accounting requirements as

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

well as equity conditions imposed by the Ministry of International Trade and Industry.

As part of the listing process, the corporation will have to fulfill criteria like histo

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

ical profitability, capital requirements, business activity and independence, background and continuity of key management.

A corporation that plan to list must also fulfill qu

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

ntitative and qualitative criteria. Once it has done so, the merchant bank will examine its shareholder's strategy. For instance, if the shareholders want to focus on busines

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

s expansion, the merchant bank will ensure the IPO is structured to facilitate funds for such expansion. If they want to realize as part of their investment, the merchant bank

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

will include an offer for sale plus a public issue.

Through a public listing, a fast-developing corporation can tap funds from the capital market for business expansion activi

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

ties. An IPO will help the business have greater diversity in funding activities. In a broader market-based environment, the corporation will have greater access to markets a

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

d opportunities for growth abroad or even acquisitions.

The IPO establishes a market-based value for companies, enabling promoters to gauge market acceptance of products and s

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

rvices while allowing for the realization of investments made in the early stages of growth.

One of the main disadvantages of an IPO is that the corporation would be subject t

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

o public disclosure requirements, corporate governance standards and accountability. An IPO will also result in dilution of control of the company.

Increased publicity of cor

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

orate transaction, financials and other aspects of the business's performance will mean changing the way a business operates. Another disadvantage is that the performance of a

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

company's stock when going to market is influenced by the prevailing market conditions.

Other than assisting in a company's listing plans, the merchant bank will also try to

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

elp to improve the company's overall performance. For instance, if the company has debts, the merchant bank can securitize the debt by packaging it into a debt instrument and

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

elling it. In this way, it'll improve the company's profitability by taking out the borrowings and removing the interest cost.

Good investment banking advisers will make the

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

whole process easier for a growing corporation. In any listing exercise, they guide the corporation through various stages like moving into an environment of greater public sc

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

utiny. They also help to transform a corporation from a one-man show into a company that can deal with investors and customers as well as negotiate with suppliers, auditors an

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

d the regulators.

Finally, some of the pertinent issues often overlooked by the corporations are the costs and added responsibilities placed on them post-IPO. Greater public

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

crutiny of accounts, periodical announcements, board composition restrictions and increased corporate governance are among the new responsibilities placed on a company post-IPO

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.mainsubjects.org.ua/article/2426/mainsubjects-Incorporation-An-IPO.html">Incorporation: An IPO</a>

BB link (for phorums):
[url=http://www.mainsubjects.org.ua/article/2426/mainsubjects-Incorporation-An-IPO.html]Incorporation: An IPO[/url]

Dutch Disease gets its name from an economic phenomenon seen in Holland. The discovery of natural gas reserves in Holland in the 1960s led to a slump in other sectors like manufacturing. Dutch Disease is the recession that hits other sectors when one industry dominates, or increases its exports.

In our final installment of medical billing and the GE0 record for electronic claims submissions, we cover fields 21 through 30. This includes a note on multiple product billing.

The business world is growing more competitive by the minute. In a fast paced society such as our own, it is very important for business professionals to stay on top of their game. When trying to win over a new client, it may be necessary at times to do a little schmoozing with the corporate snobs. Corporate gift giving is a great way to show a potential client that you mean business.

Tags

Links

Main Subject - Incorporation: An IPO

Related Articles: